Bioterror is the real threat. At the most recent joint US-Korea wargames, held on the border of North and South Korea, biowarfare was one of the threats introduced, to which allied forces had little to no defense. That exercise drove home the importance of biowarfare preparedness, and the military is currently scrambling to get up ...

EpiVax is attending the Immunogenicity Summit in Bethesda this week. Look for Leslie and Annie in person (Annie is usually at the microphone asking questions about HLA associations). We will be piloting some new slides on Epitope Networks. (For more on that, see the link to our CHO/Host Cell protein talk, which is also available ...

Our Tregitope tour continues this month and on through the fall including stops in Orlando, Bethesda and Yokohama. Take a look at the list below and let us know if you’d like us to visit you while we’re in the area. ICIW 2012 Tutorial Session 10/7 – 10/10 In conjunction with: ACM International Conference on Bioinformatics and Computational ...

EpiVax Grant for treatment of Pompe Disease brings SBIR infusion to $3.4M for Proof of Principle Studies  Providence, RI – Providence-based biotech EpiVax, Inc. was awarded a new NIH SBIR Phase II grant totaling $300,000 in funding from the National Institutes of Health (NIH) NIAID for the first year of a two year program to application of Tregitope to Pompe ...

EpiVax, Inc, a leader in genome-derived vaccines, announced today that it has received a $750,000 SBIR Phase Igrant to reengineer factor eight (FVIII), the primary therapeutic used to control bleeding and foster wound healing in hemophiliacs.

The Third Immunoinformatics and Computational Immunology Workshop will be held in conjunction with the ACM International Conference on Bioinformatics and Computational Biology in Orlando, FL on October 7-10 2012. The main theme of this meeting is “Bridging Immunology and Computer Science“. Nowadays computational methods are integral to virtually every research and development project in every discipline. ...

What’s the “I” in Biotechnology? We’re having a contest – on line and in person (at Bio). We challenge you to write 250 words on why you engage in Biotechnology. What’s your passion? What’s the story? What’s the impact? Let the world know. The best essays will be published on right here at our “Thinking out ...

14 years ago today, I was making pancakes for Bill in my kitchen, because EpiVax offices were on the third floor of my house. We were a virtual startup – no lab, but great coffee, home-made pancakes, and lots of innovative ideas about how to make new vaccines and biotherapeutics. At the end of the ...

Even though there are as many kinds of Tregs as there are types of tapas in Granada, there is only one Tregitope. The copas are flowing, and the Tregitope discovery (OK, make that SEVERAL Tregitopes) is being presented to the >3,000 participants at Autoimmunity 2012. The excitement is palpable . . .

Vaccines on demand? Yes we can. Our team is connected via international teleconferencing to four other academic and biotech company laboratories across the globe, including scientists in Germany and Denmark, a biochemist in Seattle and a vaccine developer at Harvard . . . EpiVax will play a key role in a new “faster, safer” vaccines ...

Providence-based biotech EpiVax, Inc. was awarded a new NIH SBIR Phase II grant totaling $1.5M in funding from the National Institutes of Health’s (NIH) NIDDK to explore formulation, dose, route and delivery vehicle for Tregitope through the NIH Small Business Innovation Research (SBIR) program. EpiVax anticipates receiving an additional SBIR award of approximately $775,000 within ...

The 4th Annual Tregitope update will be held in Baltimore Maryland on April 20th, 2012 (Click here for more information). Dr. Srini Kaveri of the Centre de Recherche des Cordeliers (INSERM) in Paris will provide an update on the mechanism of action of IVIG with an eye to parallels with Tregitope. A wide range ...

The Westin Seminar is back! Join us in Tokyo on March 16th to discuss immunogenicity risk and mitigation.

Come participate in one of the following hands-on demonstrations of our bioinformatics tools!  Each of these workshops features presentations and demonstrations led by our expert immunoinformaticians. Learn from the best! Hands-on Workshops! 5th Antibody Generation, Engineering & Design Conference Frankfurt, Germany Le Meridien Parkhotel, Frankfurt, Germany 29th of February 2012 Half-Day Workshop February 29th: Latest Advances in Reducing the Risk of ...

It’s a New Year (2012) and our resolution is to keep you better informed. Here’s a list of our upcoming conferences. . . .